Where are we, and where are we heading? Map and compass will be provided!
Join international experts in the field of prostate cancer as they navigate the biomarker jungle.
Oslo Cancer Cluster members, specialists, healthcare professionals and all interested parties are invited to gather at this forum to network and discuss research, developments, and opportunities in the rapidly expanding field of personalized medicine. This R&D Networks event will highlight aspects of current clinical work and R&D concerning diagnosis, treatment, and follow-up of metastatic prostate cancer.
This meeting will moderated by Sigbjørn Smeland, Chief Physician, Department of Oncology, Oslo University Hospital
Overview of presentations, 3pm – 6pm:
The Role of Tumour Microenvironment in Metastasis and Progression of Prostate Cancer
Gabri van der Pluijm, Associate Professor, Department of Urology, Leiden University Medical Center
The Evolutionary History of Lethal Metastatic Prostate Cancer
Steve Bova, Finnish Distinguished Professor, Institute of Biosciences and Medical Technology University of Tampere and Tampere University of Technology
ProstMARK – A Norwegian Prostate Cancer Biomarker Consortium
Kristin Austlid Taskén, Professor, Institute for Cancer Research, Oslo University Hospital
This R&D Networks Meeting will be hosted by Oslo Cancer Cluster in collaboration with Astellas and Bayer.